Navigation Links
Lubris, Biomodels Report on Potential New Therapy for Osteoarthritis
Date:10/19/2009

an two decades of research by Dr. Jay and his team, in which they have shown that lubricin is a key component of human synovial fluid, itself a requirement for the normal function and lubrication of healthy joints.

Abstract:

http://acr.confex.com/acr/2009/webprogram/Paper13868.html

About Lubris LLC

Lubris, a Massachusetts-based startup company, is developing lubricin commercially and holds exclusive worldwide patent rights to make, use, and sell lubricin. The company is in the process of accessing capital markets to develop and commercialize lubricin-containing products in various orthopedic and other indications.

About Biomodels LLC

Biomodels (www.biomodels.com), a preclinical drug research organization founded in 1997, develops and conducts predictive translational studies for biotechnology and pharmaceutical companies, particularly in the areas of cancer, cancer supportive care, radiation therapy, and inflammatory diseases.

The company, based in Watertown, MA, specializes in (non-GLP) efficacy studies that optimize dose, schedule and define mechanism of action. The company also has expertise in modeling inflammatory diseases, including those conditions affecting the gastrointestinal tract. Biomodels' studies enable organizations to more readily identify lead compounds, decrease the time to a clinical trial and increase the chance of clinical success.

SOURCE Biomodels


'/>"/>
SOURCE Biomodels
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Biomodels Expands Efforts in Cancer Supportive Care, Pulmonary Fibrosis; Preclinical Research Organization Names Dr. Stephen T. Sonis as Partner
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... from roadside bombs to freeway crashes. Traumatic injury, the ... 44, often overwhelms the body,s natural blood-clotting process. , ... team led by Erin Lavik, a new Case Western ... student, James P. Bertram, built synthetic platelets that show ... is published in Science Translational Medicine ., The ...
(Date:12/16/2009)... Organisms turn microgears in suspended solution by swimming ... ... 2009 -- Scientists at the U.S. Department of Energy’s (DOE) ... that common bacteria can turn microgears when suspended in a ... for energy. , , ,“The gears are a million times ...
(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), today announced ... David Pendarvis to its board of directors. ... F. Buechler, Ph.D., was president, chief scientific officer ... 1994, Dr. Buechler was Biosite,s director of chemistry. ... senior research scientist for the diagnostics research and ...
(Date:12/16/2009)... Filtration and Separations Society will hold its 23rd Annual Technical Conference ... in San Antonio, Texas. To further impact the separation society and ... proud to announce that the 2010 AFS Annual Technical Conference will ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- The ...
Breaking Biology Technology:Researchers take the inside route to halt bleeding 2Argonne Scientists Use Bacteria to Power Simple Machines 2Argonne Scientists Use Bacteria to Power Simple Machines 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4
... Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) announced today that ... has granted CTI,s request to transfer,the listing of its ... NASDAQ,Capital Market, which will be effective with the open ... continue to trade under the ticker symbol,CTIC. , ...
... Inc. (Nasdaq: MEDX ) announced today that it ... Healthcare Conference at 8:30 a.m. Pacific Time (11:30 a.m. Eastern ... webcast live and will be available in the Investor Relations ... archived edition of the presentation will be available following the ...
... that The Michael J. Fox Foundation has awarded it ... collaboration with The Parkinson,s Institute to evaluate Omeros, recent ... Parkinson,s disease. Located in regions of the brain responsible ... its novel target to the treatment of any movement ...
Other Biology Technology:Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 2Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 3Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 3
(Date:12/16/2009)... Maryland School of Medicine researcher will lead the coordinating ... scientists in the field of stem cell research. Michael ... was chosen by the National Heart, Lung and Blood ... of national experts, which will be called the NHLBI ... funded by a $30 million grant over seven years. ...
(Date:12/16/2009)... Dec. 1 GestureTek Inc. today ... 3.0 - a turnkey, portable, plug and ... exhibits, entertainment and touring promotions. GestureTek is ... patents in camera-enabled gesture recognition technology for ... Guaranteed for quality, the CUBE has TUV, ...
(Date:12/16/2009)... REDWOOD SHORES, Calif. and PALM HARBOR, Fla., ... ("CIC") (OTC Bulletin Board: CICI), a leading ... process automation in the financial industry* and ... and Docubase Systems Inc. ("Docubase"), a leading ... announced today that they have entered an ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Announcing ISMPP EU 2010 the First European Meeting of the International Society for Medical Publication Professionals Royal College of Physicians 15171 1Announcing ISMPP EU 2010 the First European Meeting of the International Society for Medical Publication Professionals Royal College of Physicians 15171 2Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 1Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 2Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 3Safe Life Ramps Production Capacity of Comfortable Breathable N95 Respirator Amid Worldwide Shortage 6997 4European Radiotherapy Pioneers Deliver First Varian RapidArc 28TM 29 Treatment for Rectal Carcinoma Patient 6995 1European Radiotherapy Pioneers Deliver First Varian RapidArc 28TM 29 Treatment for Rectal Carcinoma Patient 6995 2European Radiotherapy Pioneers Deliver First Varian RapidArc 28TM 29 Treatment for Rectal Carcinoma Patient 6995 3
... risk of cardiovascular events -- a combined endpoint including ... -- in both men and women, according to a ... Duke University Medical Center cardiologist. , However, the researchers ... between the sexes. For men, aspirin lowered the risk ...
... that transplanted stem cells can regenerate damaged heart muscle in ... an intravenous infusion of adult mesenchymal stem cells from healthy ... tissue. , A unique benefit of the stem cell product ... IV line. Other therapies require delivery to the site ...
... are developing a method to determine in a matter of ... just by looking at the pattern of active genes in ... today at the ASM Biodefense Research Meeting. , "Effective prophylaxis ... rely upon early diagnosis and rapid initiation of therapy. ...
Other Biology News:Aspirin reduces cardiovascular risks in men and women -- but differently 2Aspirin reduces cardiovascular risks in men and women -- but differently 3Stem cell study for patients with heart attack damage seeks to regenerate heart muscle 2Stem cell study for patients with heart attack damage seeks to regenerate heart muscle 3Gene patterns in white blood cells quickly diagnose disease 2
The Trans-Blot Plus gel and cassette assembly tray is used to hold the Trans-Blot Plus gel holder cassette, buffer, and other materials for the gel and membrane sandwich during their assembly....
... The Biomek FXP is the latest entry ... for greater positional accuracy and increased robustness, it ... application. It can be configured with either one ... capacity, the Biomek FXP sets the standard for ...
... By incorporating a wide range of next-generation ... sets a new standard for flexible laboratory ... handling including pipetting, dilution, dispensing, and ... thats as powerful and flexible as it ...
BD Falcon, microtest ELISA plate 96 well flat-bottom, clear. Polystyrene, nonsterile, no lid (25/sp, 100/ca) Packaging: 25 / pack, 100 / case ...
Biology Products: